James Franklin
Family Medicine · Greenville, SCNPI 1932117298
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AstraZeneca at 29.3% of the total.
Across 67 payments — averaging $19.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$391
- Amarin Pharma, Inc.$109
- GSK$107
- Amgen$78
- AbbVie$77
- Merck$73
- plus $500 from 14 others
Across 107 payments — averaging $34,156 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2.9M
- Novartis$506K
- Amgen$148K
- Johnson & Johnson$68K
- Abbott$37K
- Pfizer$17K
- plus $757 from 2 others
What the payments were for
- Food & beverage$1,335100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $391 |
| Amarin Pharma, Inc. | 6 | $109 |
| GSK | 7 | $107 |
| Amgen | 3 | $78 |
| AbbVie | 5 | $77 |
| Merck | 5 | $73 |
| Lilly USA, LLC | 4 | $65 |
| Novo Nordisk | 4 | $62 |
| Boehringer Ingelheim | 3 | $54 |
| Pfizer | 3 | $50 |
| Avanir Pharmaceuticals, Inc. | 3 | $46 |
| Philips North America LLC | 2 | $45 |
| Sunovion Pharmaceuticals Inc. | 2 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| Johnson & Johnson | 2 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$119
How this compares
$1,335 in reported general payments places this provider in the 65th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 21 | $141,333 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Greenville
- Steve HamberisGreenville$19K
- Richard LelandGreenville$19K
- Saria SaccocioGreenville$17K
- Eric FaileGreenville$15K
- Naveen BethiGreenville$14K
- James BridgemanGreenville$13K
- Angela SellGreenville$13K
- Stephen BruntonWinnsboro$1.3M
- Richard WilkesMt Pleasant$216K
- Andrew MartinColumbia$205K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.